Evaluation of a New Silicone Hydrogel Contact Lens

Sponsor
Bausch & Lomb Incorporated (Industry)
Overall Status
Completed
CT.gov ID
NCT01309880
Collaborator
(none)
66
1
2
1
64.8

Study Details

Study Description

Brief Summary

The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses developed by Bausch + Lomb.

Condition or Disease Intervention/Treatment Phase
  • Device: Test lens
  • Device: Air Optix Aqua
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Official Title:
A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens
Study Start Date :
Dec 1, 2010
Actual Primary Completion Date :
Dec 1, 2010
Actual Study Completion Date :
Jan 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Air Optix Aqua

Ciba Vision daily wear contact lens

Device: Air Optix Aqua
Air Optix Aqua contact lens worn on a daily wear basis

Experimental: Test Lens

Investigational silicone hydrogel contact lens

Device: Test lens
Investigational silicone hydrogel contact lens worn on a daily wear basis

Outcome Measures

Primary Outcome Measures

  1. Visual Acuity [Dispensing & 1-week follow up]

    Distance high contrast logMAR lens visual acuity (VA) between the Air Optix Aqua lens and the Test Lens at Dispensing and at 1-Week Follow-up.

Secondary Outcome Measures

  1. Slit Lamp Findings [1 week]

    Measured on a scale of 0-4 where 0=none, 1=trace, 2=mild, 3=moderate, and 4=severe for edema, microcysts, corneal staining, limbal injection, bulbar injection, upper lid tarsal conjunctival abnormalities, corneal neovascularization and corneal infiltrates.

  2. Comfort [1 Weeks]

    At 1-Week Follow-up, participants rated lens comfort on a scale of 0 to 100, with 100 being the most favorable score.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.

  • Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.

Exclusion Criteria:
  • Have worn gas permeable (GP) contact lenses within last 30 days or polymethylmethacrylate (PMMA) lenses within last 3 months.

  • Any systemic disease affecting ocular health.

  • Using any systemic or topical medications that will affect ocular physiology or lens performance.

  • An active ocular disease, any corneal infiltrative response or are using any ocular medications.

  • Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.

  • Allergic to any component in the study care products.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bausch & Lomb, Incorporated Rochester New York United States 14609

Sponsors and Collaborators

  • Bausch & Lomb Incorporated

Investigators

  • Study Director: Beverly Barna, Bausch & Lomb Incorporated

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bausch & Lomb Incorporated
ClinicalTrials.gov Identifier:
NCT01309880
Other Study ID Numbers:
  • 686E
First Posted:
Mar 7, 2011
Last Update Posted:
Feb 23, 2015
Last Verified:
Feb 1, 2015
Keywords provided by Bausch & Lomb Incorporated
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details This study was a randomized, bilateral, subject-masked, two-week study with a crossover at one week, conducted at three sites in the United States (US). First participant was enrolled on 12/01/2010, last participant exited the study on 12/23/2010.
Pre-assignment Detail A total of 66 participants (132 eyes) were enrolled in the study. One-half (33) were randomized to receive the investigational RD2117-01 ID4 contact lens first, and the other half (33) was randomized to receive the Air Optix Aqua contact lens first then crossed over after 1 week. All participants completed the study.
Arm/Group Title Air Optix Aqua Then Test Lens Test Lens Then Air Optix Aqua
Arm/Group Description Ciba Vision Air Optix Aqua contact lens. Lenses were worn on a daily wear basis. After one week participants crossed over to the Test lens. All subjects were provided with Bausch + Lomb renu® fresh™ multi-purpose solution and lens cases for daily rinsing, cleaning, disinfecting, and storing their lenses, and Bausch + Lomb Sensitive Eyes® Rewetting Drops for use as needed during the study. The test lens was an Investigational silicone hydrogel contact lens. Lenses were worn on a daily wear basis. After one week participants crossed over to Ciba Vision Air Optix Aqua contact lens.. All subjects were provided with Bausch + Lomb renu® fresh™ multi-purpose solution and lens cases for daily rinsing, cleaning, disinfecting, and storing their lenses, and Bausch + Lomb Sensitive Eyes® Rewetting Drops for use as needed during the study.
Period Title: Overall Study
STARTED 33 33
COMPLETED 33 33
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title Overall Study
Arm/Group Description One-half of the participants (33) were randomized to receive the investigational RD2117-01 ID4 contact lens, and the other half (33) was randomized to receive the Air Optix Aqua contact lens. Both groups wore the lenses on a daily wear basis. After one week of wearing the first lens type, the subjects returned for an exam and crossed over to the second lens type for one week.
Overall Participants 66
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
36.2
(9.6)
Sex: Female, Male (Count of Participants)
Female
47
71.2%
Male
19
28.8%
Region of Enrollment (participants) [Number]
United States
66
100%

Outcome Measures

1. Primary Outcome
Title Visual Acuity
Description Distance high contrast logMAR lens visual acuity (VA) between the Air Optix Aqua lens and the Test Lens at Dispensing and at 1-Week Follow-up.
Time Frame Dispensing & 1-week follow up

Outcome Measure Data

Analysis Population Description
All Eligible, Dispensed Eyes
Arm/Group Title Air Optix Aqua Test Lens
Arm/Group Description Ciba Vision daily wear contact lens Air Optix Aqua: Air Optix Aqua contact lens worn on a daily wear basis Investigational silicone hydrogel contact lens Test lens: Investigational silicone hydrogel contact lens worn on a daily wear basis
Measure Participants 66 66
Measure eyes 132 132
Dispensing
-0.083
(0.071)
-0.085
(0.071)
1-Week Follow-up
-0.084
(0.077)
-0.078
(0.077)
2. Secondary Outcome
Title Slit Lamp Findings
Description Measured on a scale of 0-4 where 0=none, 1=trace, 2=mild, 3=moderate, and 4=severe for edema, microcysts, corneal staining, limbal injection, bulbar injection, upper lid tarsal conjunctival abnormalities, corneal neovascularization and corneal infiltrates.
Time Frame 1 week

Outcome Measure Data

Analysis Population Description
All Dispensed Eyes
Arm/Group Title Air Optix Aqua Test Lens
Arm/Group Description Ciba Vision daily wear contact lens Air Optix Aqua: Air Optix Aqua contact lens worn on a daily wear basis Investigational silicone hydrogel contact lens Test lens: Investigational silicone hydrogel contact lens worn on a daily wear basis
Measure Participants 66 66
Measure eyes 132 132
Grade 0
46
82
Grade 1
86
50
Grade 2
0
0
> Grade 2
0
0
3. Secondary Outcome
Title Comfort
Description At 1-Week Follow-up, participants rated lens comfort on a scale of 0 to 100, with 100 being the most favorable score.
Time Frame 1 Weeks

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Air Optix Aqua Test Lens
Arm/Group Description Ciba Vision daily wear contact lens Air Optix Aqua: Air Optix Aqua contact lens worn on a daily wear basis Investigational silicone hydrogel contact lens Test lens: Investigational silicone hydrogel contact lens worn on a daily wear basis
Measure Participants 66 66
Measure eyes 132 132
Least Squares Mean (Standard Deviation) [units on a scale]
85.5
(19.5)
81.8
(19.5)

Adverse Events

Time Frame 1 week
Adverse Event Reporting Description
Arm/Group Title Air Optix Aqua Test Lens
Arm/Group Description Ciba Vision daily wear contact lens Air Optix Aqua: Air Optix Aqua contact lens worn on a daily wear basis Investigational silicone hydrogel contact lens Test lens: Investigational silicone hydrogel contact lens worn on a daily wear basis
All Cause Mortality
Air Optix Aqua Test Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Air Optix Aqua Test Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/66 (0%) 0/66 (0%)
Other (Not Including Serious) Adverse Events
Air Optix Aqua Test Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/66 (0%) 0/66 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

Results Point of Contact

Name/Title Dr. Robert Steffen
Organization Bausch & Lomb
Phone 585 338 6399
Email robert.steffen@bausch.com
Responsible Party:
Bausch & Lomb Incorporated
ClinicalTrials.gov Identifier:
NCT01309880
Other Study ID Numbers:
  • 686E
First Posted:
Mar 7, 2011
Last Update Posted:
Feb 23, 2015
Last Verified:
Feb 1, 2015